No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MGRX Mangoceuticals
- 0.282
- +0.023+8.92%
Close Apr 17 16:00 ET
- 0.280
- -0.002-0.71%
Post 18:28 ET
6.66MMarket Cap-655P/E (TTM)
0.295High0.251Low248.19KVolume0.259Open0.259Pre Close69.49KTurnover1.79%Turnover RatioLossP/E (Static)23.62MShares2.38052wk High8.55P/B3.90MFloat Cap0.14352wk Low--Dividend TTM13.84MShs Float4.370Historical High--Div YieldTTM17.03%Amplitude0.143Historical Low0.279Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Mangoceuticals Signs Securities Purchase Deal; Mexican Unit Enters Technical Deal With Emifarma
Mangoceuticals' (MGRX) said in a regulatory filing late Thursday that it has signed a securities purchase agreement to sell 1,500 shares of series B convertible preferred stock for approximately $1.7
Mangoceuticals Partners With Emifarma for ED Product Development
Express News | Mangoceuticals Subsidiary, Mangorx Mexico, Executes Technical Agreement With Mexican Pharmaceutical Manufacturer for Initial Development and Production of Its Mango Erectile Dysfunction (Ed) Products
This Mangoceuticals Insider Increased Their Holding In The Last Year
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
GainersFarmer Bros (NASDAQ:FARM) stock increased by 4.8% to $3.48 during Tuesday's after-market session. The company's market cap stands at $73.3 million. Pricesmart (NASDAQ:PSMT) stock moved upwards
Mangoceuticals Shareholders Back Strategic Moves at Special Meeting
Comments
$Mangoceuticals(MGRX.US$
NEWS
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
Mangoceuticals, Inc. (NASDAQ: MGRX) announces a technical agreement with Emifarma S.A. de C.V for the development and testing of Mango ED products for the Mexican and Latin American markets. This marks a significant step towards obtaining certification from COFEPRIS, o...
NEWS
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
Mangoceuticals, Inc. (NASDAQ: MGRX) announces a technical agreement with Emifarma S.A. de C.V for the development and testing of Mango ED products for the Mexican and Latin American markets. This marks a significant step towards obtaining certification from COFEPRIS, o...
$BitFuFu (FUFU.US)$ Good morning Traders in the world Good Luck to you all 👋 $BitFuFu (FUFU.US)$ $Haoxi Health Technology (HAO.US)$ $Jin Medical International (ZJYL.US)$ $Lavoro(LVRO.US$$Golden Sun Health Technology(GSUN.US$$Fractyl Health(GUTS.US$$Etao International(ETAO.US$$Oblong(OBLG.US$$Mangoceuticals(MGRX.US$
Update
$Mangoceuticals(MGRX.US$ MangoRx Launches 'PRIME' By MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Treatment
Benzinga· 1 min ago
Benzinga· 1 min ago
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg